Slayback is welcoming a new executive. Dave Picard is joining as the chief commercial officer.
Picard is a senior executive with an established track record of successfully leading sales teams and growing businesses. Throughout his career, he has held commercial positions of increasing responsibility at companies like AmerisourceBergen, Sandoz and Bristol-Myers Squibb. His experience spans across various sales channels including hospital, clinic, retail and specialty.
Most recently, he was at ABC where he was the senior vice president, of global generic pharmaceuticals. He was responsible for elevating ABC's presence in the generic injectable space by building and maintaining relationships with generic injectable manufacturers, growing the PRxO injectable formulary and building the generic injectable sourcing team. Picard also was instrumental in jumpstarting ABC's presence in the burgeoning biosimilar space.